By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material. 7500 Security Boulevard, Baltimore, MD 21244. There has been no change in content to the LCD. This site needs JavaScript to work properly. Social Security Act (Title XVIII) Standard References: This Billing and Coding Article provides billing and coding guidance for Local Coverage Determination (LCD) L35049 Monitored Anesthesia Care. The document is broken into multiple sections. The page could not be loaded. *Note: Use of the diagnosis codes K85.00-K85.32, K85.80-K85.92, K86.0-K86.1 must be representative of the patients hepatic failure condition (serum bilirubin greater than 3). Federal government websites often end in .gov or .mil. an effective method to share Articles that Medicare contractors develop. Epub 2018 Dec 17. or complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. You can use your browser's Print function (Ctrl-P on a PC or Command-P on a Mac) to view a print preview and then select PDF as the output. CMS believes that the Internet is 100-04, Medicare Claims Processing Manual, for further guidance. A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. WebThe Centers for Medicare and Medicaid Services (CMS) broadly considers anesthesia services as including moderate and deep sedation. The following CPT/HCPCS code(s) have been added to the Group 1 codes: 00731 and 00732. No other change was made to the policy. Guidelines to the Practice of Anesthesia - Revised Edition 2019. Le Guide est soumis rvision et des versions mises jour sont publies chaque anne. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. Inadomi JM, Gunnarsson CL, Rizzo JA. Your MCD session is currently set to expire in 5 minutes due to inactivity. Special conditions or criteria must be supported by documentation in the medical record. The following ICD-10-CM codes have been added to the Article for Group 1 Codes: J82.81, J82.82, J82.83, J82.89, K74.01, K74.02, T40.495A, T40.495D, and T40.495S. All Rights Reserved. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. *Note: Use of the diagnosis codes F10.10, F10.120, F10.129 must be representative of the patients acute drunken condition. Ann Med Surg (Lond). If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. Applicable FARS\DFARS Restrictions Apply to Government Use. The medical condition must be significant enough to impact on the need to provide MAC such as the patient being on medication or being symptomatic, etc. A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Dobson G, Chow L, Flexman A, Hurdle H, Kurrek M, Laflamme C, Perrault MA, Sparrow K, Stacey S, Swart P, Wong M. Can J Anaesth. Purpose: To provide guidelines for the reimbursement of anesthesia services for professional You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. If you would like to extend your session, you may select the Continue Button. As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. The following ICD-10-CM codes have undergone a descriptor change: Z88.4, Z88.5, and Z88.6. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. An asterisk (*) indicates a The Guidelines to the Practice of Anesthesia Revised Edition 2021 (the Guidelines) were prepared by the Canadian Anesthesiologists Society (CAS), which The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. recipient email address(es) you enter. The CMS established the National Correct Coding Initiative (NCCI) program to ensure the correct Complete absence of all Revenue Codes indicates Some articles contain a large number of codes. All codes and coding information have been moved from the related LCD to the article. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. Special Announcement - Guidelines to the Practice of Anesthesia - Revised Edition 2021. The following ICD-10-CM code(s) have been deleted and therefore removed from the LCD: F53 and I63.8. LCD updated on 06/28/2018 for administrative purposes. will not infringe on privately owned rights. When these codes are used and MAC has been provided, the QS modifier must be used. PMC Can J Anaesth. If MAC is used for these reasons, clinical records must be available upon request that justify the need for MAC. *Note: Use of the diagnosis codes I50.810, I50.811, I50.812, I50.813, I50.814, I50.82, I50.83, I50.84, I50.89, and I50.9 must be representative of the patients significant heart failure condition supported by the patient being on pulmonary and/or cardiac medications. LCD revised and published on 10/25/2018 effective for dates of service on and after 10/01/2018 to reflect the Annual ICD-10-CM Code Updates. Sign up to get the latest information about your choice of CMS topics in your inbox. Utilization GuidelinesIn accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, The Guidelines are subject to revision and updated versions are published annually. and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only *Note: Use of the diagnosis codes F19.10, F19.120, F19.90 must be representative of the patients drug abuse (acute, detoxification state) condition. Neither the United States Government nor its employees represent that use of At this time the 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. *Note: Use of the diagnosis codes G40.901, G40.909, G40.911, G40.919 must be representative of the patients seizure disorder condition requiring appropriate antiepileptic medication. Proposed LCD document IDs begin with the letters "DL" (e.g., DL12345). accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the The AMA assumes no liability for data contained or not contained herein. Some payers will pay per unit or per minute, but most (including many state Medicaid carriers) will either cap the minutes at some arbitrary level, or pay a flat rate. For patients with low pain thresholds or who suffer severe pain, use ICD-10-CM code G97.81. Anesthesia codes utilized to indicate the clinical condition of the patient receiving MAC: For combative patients, use ICD-10-CM code F91.9. Modifier 73: Procedure terminated before administration of anesthesia Allows 50 percent Modifier 74: Procedure terminated after administration of anesthesia Allows full payment Modifier 53 is for physician-use only and is not used by ASCs. Chapter II of the National Correct Coding Initiative Policy Manual for Medicare Services goes over the CMS Sign up to get the latest information about your choice of CMS topics. lock CMS and its products and services are The following CPT codes have been added to Group 1 of the Article: 01937, 01938, 01939, 01940, 01941, 01942. Webof anesthesia services as well as anesthesia services that are an integral part of procedural services. RSUM: Le Guide dexercice de lanesthsie, version rvise 2021 (le Guide), a t prpar par la Socit canadienne des anesthsiologistes (SCA), qui se rserve le droit de dcider des termes de sa publication et de sa diffusion. Sedation is routinely used during gastrointestinal endoscopic procedures and can be defined as a drug-induced depression in the level of consciousness. *Note: Use of the diagnosis code R56.9 must be representative of the patients unstable condition requiring multiple medications. There are different article types: Articles are often related to an LCD, and the relationship can be seen in the "Associated Documents" section of the Article or the LCD. Federal government websites often end in .gov or .mil. The following ICD-10 code(s) have been added to the LCD: Group 1 codes F32.89, F34.81, F34.89, H35.3210, H35.3211, H35.3212, H35.3213, H35.3220, H35.3221, H35.3222, H35.3223, H35.3230, H35.3231, H35.3232, H35.3233, I60.2, I63.013, I63.033, I63.113, I63.133, I63.213, I63.233, I63.313, I63.323, I63.333, I63.343, I63.413, I63.423, I63.433, I63.443, I63.513, I63.523, I63.533, I63.543, K85.00, K85.01, K85.02, K85.10, K85.11, K85.12, K85.20, K85.21, K85.22, K85.30, K85.31, K85.32, K85.80, K85.81, K85.82, K85.90, K85.91, and K85.92. *Note: Use of the diagnosis code I38 must be representative of the patients acute and unstable heart disease/condition requiring multiple medications. Nutrients. By using the diagnosis code(s) listed, the medical records must reflect the conditions as described. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Dobson G, Filteau L, Fuda G, McIntyre I, Milne AD, Milkovich R, Sparrow K, Wang Y, Young C. Can J Anaesth. Providers are reminded that not all the CPT/HCPCS codes listed can be billed with all Bill Type and/or Revenue Codes listed. Additions and revisions to the manual are noted in red font. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "I Accept". THE INFORMATION, PRODUCT, OR PROCESSES DISCLOSED HEREIN. not endorsed by the AHA or any of its affiliates. Instructions for enabling "JavaScript" can be found here. This page displays your requested Local Coverage Determination (LCD). An official website of the United States government Guidelines to the Practice of Anesthesia - Revised Edition 2018. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. Some older versions have been archived. For the following ICD-10-CM codes the code description has changed in Group 1: F01.50, F02.80, F03.90. required field. and transmitted securely. THE UNITED STATES GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN Please note that codes (CPT/HCPCS and ICD-10) have moved from LCDs to Billing & Coding Articles. Before sharing sensitive information, make sure you're on a federal government site. Webexample, anesthesia services include certain preparation and monitoring services. Coding Guidance Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. National Library of Medicine Instructions for enabling "JavaScript" can be found here. 2020 Jan;67(1):64-99. doi: 10.1007/s12630-019-01507-4. All providers who report services for Medicare payment must fully understand and follow all existing laws, regulations and rules for Medicare payment for monitored anesthesia care services and must properly submit only valid claims for them. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Epub 2017 Dec 14. This revision is not a restriction to the coverage determination; therefore, not all the fields included on the LCD are applicable as noted in this policy. Instructions for enabling "JavaScript" can be found here. License to use CDT for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Anesthesia procedures listed in the CPT/HCPCS Codes section of the related Local Coverage Article Billing and Coding: Monitored Anesthesia Care (A57361), are examples of those that are usually provided by the attending surgeon and are included in the global fee and are not separately billable. During MAC, the patients oxygenation, ventilation, circulation and temperature should be evaluated by whatever methods are deemed most suitable by the attending anesthetist. CDT is a trademark of the ADA. "JavaScript" disabled. Implanted Devices ASC surgery allowed amount includes the costs of implanted devices. The Medicare program provides limited benefits for outpatient prescription drugs. Revision Date (Medicaid): 1/1/2021 IV-6 when it is provided by the same physician performing a medical or surgical procedure except when the anesthesia service is bundled into the procedure, e.g. Injections of local anesthesia for musculoskeletal procedures (surgical or manipulative) are not separately No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be 2021 Anesthesia Conversion Factors (ZIP) - (Updated 12/29/2020) - These are the anesthesia conversion factors used to compute allowable amounts for AHA copyrighted materials including the UB‐04 codes and The views and/or positions presented in the material do not necessarily represent the views of the AHA. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt. *Note: Use of diagnosis code F40.210, F40.218, F40.220, F40.228, F40.230-F40.233, F40.240-F40.243, F40.248, F40.290-F40.291, F40.298, F40.8 should represent that the patient has a severe phobic condition. You can decide how often to receive updates. MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. If you would like to extend your session, you may select the Continue Button. It is the providers responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.The following ICD-10 codes support medical necessity and provide coverage for CPT codes: 00100, 00124, 00148, 00160, 00164, 00300, 00322, 00400, 00410, 00454, 00520, 00522, 00524, 00530, 00532, 00635, 00640, 00702, 00731, 00732, 00842, 00920, 00921, 01130, 01380, 01420, 01490, 01680, 01730, 01780, 01782, 01820, 01829, 01860, 01916, 01920, 01922, 01930, 01937, 01938, 01939, 01940, 01941, 01942, 01991, 01992, and 01999. Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period. CMS IOM reference for Publication 100-09 pertains to coding therefore it has been removed from the LCD. You can use the Contents side panel to help navigate the various sections. You can collapse such groups by clicking on the group header to make navigation easier. No changes have been made to the LCD content. Copyright © 2022, the American Hospital Association, Chicago, Illinois. Webanesthesia services policies and procedures are expected to also address the minimum qualifications and supervision requirements for each category of practitioner who is CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. radiation treatment management. *Note: I42.7, I42.9, I43 Use of the diagnosis codes in the section above must be representative of the patients severely impaired condition requiring multiple medications. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, Sepsis due to Methicillin susceptible Staphylococcus aureus, Sepsis due to Methicillin resistant Staphylococcus aureus, Sepsis due to other specified staphylococcus, Congenital iodine-deficiency syndrome, neurological type, Congenital iodine-deficiency syndrome, myxedematous type, Congenital iodine-deficiency syndrome, mixed type, Congenital iodine-deficiency syndrome, unspecified, Other iodine-deficiency related thyroid disorders and allied conditions, Subclinical iodine-deficiency hypothyroidism, Congenital hypothyroidism with diffuse goiter, Hypothyroidism due to medicaments and other exogenous substances, Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm, Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm, Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm, Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm, Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm, Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm, Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm, Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm, Thyrotoxicosis factitia without thyrotoxic crisis or storm, Thyrotoxicosis factitia with thyrotoxic crisis or storm, Other thyrotoxicosis without thyrotoxic crisis or storm, Other thyrotoxicosis with thyrotoxic crisis or storm, Thyrotoxicosis, unspecified without thyrotoxic crisis or storm, Thyrotoxicosis, unspecified with thyrotoxic crisis or storm, Type 1 diabetes mellitus with ketoacidosis without coma, Type 1 diabetes mellitus with ketoacidosis with coma, Type 1 diabetes mellitus with diabetic nephropathy, Type 1 diabetes mellitus with diabetic chronic kidney disease, Type 1 diabetes mellitus with other diabetic kidney complication, Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema, Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema, Type 1 diabetes mellitus with diabetic cataract, Type 1 diabetes mellitus with other diabetic ophthalmic complication, Type 1 diabetes mellitus with diabetic neuropathy, unspecified, Type 1 diabetes mellitus with other diabetic neurological complication, Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene, Type 1 diabetes mellitus with other circulatory complications, Type 1 diabetes mellitus with other diabetic arthropathy, Type 1 diabetes mellitus with diabetic dermatitis, Type 1 diabetes mellitus with other skin ulcer, Type 1 diabetes mellitus with other skin complications, Type 1 diabetes mellitus with periodontal disease, Type 1 diabetes mellitus with other oral complications, Type 1 diabetes mellitus with hypoglycemia with coma, Type 1 diabetes mellitus with hypoglycemia without coma, Type 1 diabetes mellitus with hyperglycemia, Type 1 diabetes mellitus with other specified complication, Type 1 diabetes mellitus with unspecified complications, Type 1 diabetes mellitus without complications, Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC), Type 2 diabetes mellitus with hyperosmolarity with coma, Type 2 diabetes mellitus with ketoacidosis without coma, Type 2 diabetes mellitus with ketoacidosis with coma, Type 2 diabetes mellitus with diabetic nephropathy, Type 2 diabetes mellitus with diabetic chronic kidney disease, Type 2 diabetes mellitus with other diabetic kidney complication, Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema, Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema, Type 2 diabetes mellitus with diabetic cataract, Type 2 diabetes mellitus with other diabetic ophthalmic complication, Type 2 diabetes mellitus with diabetic neuropathy, unspecified, Type 2 diabetes mellitus with other diabetic neurological complication, Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene, Type 2 diabetes mellitus with other circulatory complications, Type 2 diabetes mellitus with other diabetic arthropathy, Type 2 diabetes mellitus with diabetic dermatitis, Type 2 diabetes mellitus with other skin ulcer, Type 2 diabetes mellitus with other skin complications, Type 2 diabetes mellitus with periodontal disease, Type 2 diabetes mellitus with other oral complications, Type 2 diabetes mellitus with hypoglycemia with coma, Type 2 diabetes mellitus with hypoglycemia without coma, Type 2 diabetes mellitus with hyperglycemia, Type 2 diabetes mellitus with other specified complication, Type 2 diabetes mellitus with unspecified complications, Type 2 diabetes mellitus without complications, Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC), Other specified diabetes mellitus with hyperosmolarity with coma, Other specified diabetes mellitus with ketoacidosis without coma, Other specified diabetes mellitus with ketoacidosis with coma, Other specified diabetes mellitus with diabetic nephropathy, Other specified diabetes mellitus with diabetic chronic kidney disease, Other specified diabetes mellitus with other diabetic kidney complication, Other specified diabetes mellitus with other diabetic ophthalmic complication, Other specified diabetes mellitus with diabetic neuropathy, unspecified, Other specified diabetes mellitus with other diabetic neurological complication, Other specified diabetes mellitus with other circulatory complications, Other specified diabetes mellitus with diabetic dermatitis, Other specified diabetes mellitus with foot ulcer, Other specified diabetes mellitus with other skin ulcer, Other specified diabetes mellitus with other skin complications, Other specified diabetes mellitus with other oral complications, Other specified diabetes mellitus with hypoglycemia with coma, Other specified diabetes mellitus with hypoglycemia without coma, Other specified diabetes mellitus with hyperglycemia, Other specified diabetes mellitus with other specified complication, Other specified diabetes mellitus with unspecified complications, Other specified diabetes mellitus without complications, Other specified disorders of pancreatic internal secretion, Disorder of pancreatic internal secretion, unspecified, Secondary hyperparathyroidism, not elsewhere classified, Other specified disorders of parathyroid gland, Disorder of parathyroid gland, unspecified, Syndrome of inappropriate secretion of antidiuretic hormone, Hyperfunction of pituitary gland, unspecified, Hypothalamic dysfunction, not elsewhere classified, Alcohol-induced pseudo-Cushing's syndrome, Congenital adrenogenital disorders associated with enzyme deficiency, Drug-induced adrenocortical insufficiency, Other specified disorders of adrenal gland, Disorders of endocrine glands in diseases classified elsewhere, Morbid (severe) obesity due to excess calories, Morbid (severe) obesity with alveolar hypoventilation, Cystic fibrosis with pulmonary manifestations, Transfusion associated circulatory overload, Other disorders of electrolyte and fluid balance, not elsewhere classified, Postprocedural adrenocortical (-medullary) hypofunction, Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Vascular dementia, unspecified severity, with agitation, Vascular dementia, unspecified severity, with other behavioral disturbance, Vascular dementia, unspecified severity, with psychotic disturbance, Vascular dementia, unspecified severity, with mood disturbance, Vascular dementia, unspecified severity, with anxiety, Vascular dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Vascular dementia, mild, with other behavioral disturbance, Vascular dementia, mild, with psychotic disturbance, Vascular dementia, mild, with mood disturbance, Vascular dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Vascular dementia, moderate, with agitation, Vascular dementia, moderate, with other behavioral disturbance, Vascular dementia, moderate, with psychotic disturbance, Vascular dementia, moderate, with mood disturbance, Vascular dementia, moderate, with anxiety, Vascular dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Vascular dementia, severe, with agitation, Vascular dementia, severe, with other behavioral disturbance, Vascular dementia, severe, with psychotic disturbance, Vascular dementia, severe, with mood disturbance, Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Dementia in other diseases classified elsewhere, unspecified severity, with agitation, Dementia in other diseases classified elsewhere, unspecified severity, with other behavioral disturbance, Dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance, Dementia in other diseases classified elsewhere, unspecified severity, with mood disturbance, Dementia in other diseases classified elsewhere, unspecified severity, with anxiety, Dementia in other diseases classified elsewhere, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Dementia in other diseases classified elsewhere, mild, with agitation, Dementia in other diseases classified elsewhere, mild, with other behavioral disturbance, Dementia in other diseases classified elsewhere, mild, with psychotic disturbance, Dementia in other diseases classified elsewhere, mild, with mood disturbance, Dementia in other diseases classified elsewhere, mild, with anxiety, Dementia in other diseases classified elsewhere, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Dementia in other diseases classified elsewhere, moderate, with agitation, Dementia in other diseases classified elsewhere, moderate, with other behavioral disturbance, Dementia in other diseases classified elsewhere, moderate, with psychotic disturbance, Dementia in other diseases classified elsewhere, moderate, with mood disturbance, Dementia in other diseases classified elsewhere, moderate, with anxiety, Dementia in other diseases classified elsewhere, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Dementia in other diseases classified elsewhere, severe, with agitation, Dementia in other diseases classified elsewhere, severe, with other behavioral disturbance, Dementia in other diseases classified elsewhere, severe, with psychotic disturbance, Dementia in other diseases classified elsewhere, severe, with mood disturbance, Dementia in other diseases classified elsewhere, severe, with anxiety, Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Unspecified dementia, unspecified severity, with agitation, Unspecified dementia, unspecified severity, with other behavioral disturbance, Unspecified dementia, unspecified severity, with psychotic disturbance, Unspecified dementia, unspecified severity, with mood disturbance, Unspecified dementia, unspecified severity, with anxiety, Unspecified dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Unspecified dementia, mild, with agitation, Unspecified dementia, mild, with other behavioral disturbance, Unspecified dementia, mild, with psychotic disturbance, Unspecified dementia, mild, with mood disturbance, Unspecified dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Unspecified dementia, moderate, with agitation, Unspecified dementia, moderate, with other behavioral disturbance, Unspecified dementia, moderate, with psychotic disturbance, Unspecified dementia, moderate, with mood disturbance, Unspecified dementia, moderate, with anxiety, Unspecified dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, Unspecified dementia, severe, with agitation, Unspecified dementia, severe, with other behavioral disturbance, Unspecified dementia, severe, with psychotic disturbance, Unspecified dementia, severe, with mood disturbance, Unspecified dementia, severe, with anxiety, Amnestic disorder due to known physiological condition, Delirium due to known physiological condition, Psychotic disorder with hallucinations due to known physiological condition, Catatonic disorder due to known physiological condition, Psychotic disorder with delusions due to known physiological condition, Mood disorder due to known physiological condition, unspecified, Mood disorder due to known physiological condition with depressive features, Mood disorder due to known physiological condition with major depressive-like episode, Mood disorder due to known physiological condition with manic features, Mood disorder due to known physiological condition with mixed features, Anxiety disorder due to known physiological condition, Other specified mental disorders due to known physiological condition, Alcohol abuse with intoxication, uncomplicated, Alcohol abuse with intoxication, unspecified, Alcohol abuse with alcohol-induced mood disorder, Alcohol abuse with alcohol-induced psychotic disorder with delusions, Alcohol abuse with alcohol-induced psychotic disorder with hallucinations, Alcohol abuse with alcohol-induced psychotic disorder, unspecified, Alcohol abuse with alcohol-induced anxiety disorder, Alcohol abuse with alcohol-induced sexual dysfunction, Alcohol abuse with other alcohol-induced disorder, Alcohol abuse with unspecified alcohol-induced disorder, Alcohol dependence with intoxication delirium, Alcohol dependence with withdrawal, uncomplicated, Alcohol dependence with withdrawal delirium, Alcohol dependence with withdrawal with perceptual disturbance, Alcohol dependence with withdrawal, unspecified, Alcohol dependence with alcohol-induced mood disorder, Alcohol dependence with alcohol-induced psychotic disorder with delusions, Alcohol dependence with alcohol-induced psychotic disorder with hallucinations, Alcohol dependence with alcohol-induced psychotic disorder, unspecified, Alcohol dependence with alcohol-induced persisting amnestic disorder, Alcohol dependence with alcohol-induced persisting dementia, Alcohol dependence with alcohol-induced anxiety disorder, Alcohol dependence with alcohol-induced sexual dysfunction, Alcohol dependence with other alcohol-induced disorder, Alcohol dependence with unspecified alcohol-induced disorder, Alcohol use, unspecified with intoxication, uncomplicated, Alcohol use, unspecified with intoxication delirium, Alcohol use, unspecified with intoxication, unspecified, Alcohol use, unspecified with alcohol-induced mood disorder, Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions, Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations, Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified, Alcohol use, unspecified with alcohol-induced persisting amnestic disorder, Alcohol use, unspecified with alcohol-induced persisting dementia, Alcohol use, unspecified with alcohol-induced anxiety disorder, Alcohol use, unspecified with alcohol-induced sexual dysfunction, Alcohol use, unspecified with other alcohol-induced disorder, Alcohol use, unspecified with unspecified alcohol-induced disorder, Opioid abuse with intoxication, uncomplicated, Opioid abuse with intoxication with perceptual disturbance, Opioid abuse with intoxication, unspecified, Opioid abuse with opioid-induced mood disorder, Opioid abuse with opioid-induced psychotic disorder with delusions, Opioid abuse with opioid-induced psychotic disorder with hallucinations, Opioid abuse with opioid-induced psychotic disorder, unspecified, Opioid abuse with opioid-induced sexual dysfunction, Opioid abuse with other opioid-induced disorder, Opioid abuse with unspecified opioid-induced disorder, Opioid dependence with intoxication with perceptual disturbance, Opioid dependence with opioid-induced psychotic disorder, unspecified, Opioid dependence with opioid-induced sexual dysfunction, Opioid dependence with other opioid-induced disorder, Opioid use, unspecified with intoxication, uncomplicated, Opioid use, unspecified with intoxication delirium, Opioid use, unspecified with intoxication with perceptual disturbance, Opioid use, unspecified with intoxication, unspecified, Opioid use, unspecified with opioid-induced mood disorder, Opioid use, unspecified with opioid-induced psychotic disorder with delusions, Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations, Opioid use, unspecified with opioid-induced psychotic disorder, unspecified, Opioid use, unspecified with opioid-induced sexual dysfunction, Opioid use, unspecified with other opioid-induced disorder, Opioid use, unspecified with unspecified opioid-induced disorder, Cannabis abuse with intoxication, uncomplicated, Cannabis abuse with intoxication delirium, Cannabis abuse with intoxication with perceptual disturbance, Cannabis abuse with intoxication, unspecified, Cannabis abuse with psychotic disorder with delusions, Cannabis abuse with psychotic disorder with hallucinations, Cannabis abuse with psychotic disorder, unspecified, Cannabis abuse with cannabis-induced anxiety disorder, Cannabis abuse with other cannabis-induced disorder, Cannabis abuse with unspecified cannabis-induced disorder, Cannabis dependence with intoxication with perceptual disturbance, Cannabis dependence with psychotic disorder, unspecified, Cannabis dependence with cannabis-induced anxiety disorder, Cannabis dependence with other cannabis-induced disorder, Cannabis use, unspecified with intoxication, uncomplicated, Cannabis use, unspecified with intoxication delirium, Cannabis use, unspecified with intoxication with perceptual disturbance, Cannabis use, unspecified with intoxication, unspecified, Cannabis use, unspecified with withdrawal, Cannabis use, unspecified with psychotic disorder with delusions, Cannabis use, unspecified with psychotic disorder with hallucinations, Cannabis use, unspecified with psychotic disorder, unspecified, Cannabis use, unspecified with anxiety disorder, Cannabis use, unspecified with other cannabis-induced disorder, Cannabis use, unspecified with unspecified cannabis-induced disorder, Sedative, hypnotic or anxiolytic abuse, uncomplicated, Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated, Sedative, hypnotic or anxiolytic abuse with intoxication delirium, Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified, Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder, Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions, Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations, Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified, Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder, Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction, Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder, Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder, Sedative, hypnotic or anxiolytic dependence, uncomplicated, Sedative, hypnotic or anxiolytic dependence, in remission, Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified, Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder, Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction, Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder, Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated, Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated, Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium, Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified, Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated, Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium, Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances, Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction, Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder, Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder, Cocaine abuse with intoxication, uncomplicated, Cocaine abuse with intoxication with delirium, Cocaine abuse with intoxication with perceptual disturbance, Cocaine abuse with intoxication, unspecified, Cocaine abuse with cocaine-induced mood disorder, Cocaine abuse with cocaine-induced psychotic disorder with delusions, Cocaine abuse with cocaine-induced psychotic disorder with hallucinations, Cocaine abuse with cocaine-induced psychotic disorder, unspecified, Cocaine abuse with cocaine-induced anxiety disorder, Cocaine abuse with cocaine-induced sexual dysfunction, Cocaine abuse with other cocaine-induced disorder, Cocaine abuse with unspecified cocaine-induced disorder, Cocaine dependence with intoxication with perceptual disturbance, Cocaine dependence with cocaine-induced psychotic disorder, unspecified, Cocaine dependence with cocaine-induced anxiety disorder, Cocaine dependence with cocaine-induced sexual dysfunction, Cocaine dependence with other cocaine-induced disorder, Cocaine use, unspecified with intoxication, uncomplicated, Cocaine use, unspecified with intoxication delirium, Cocaine use, unspecified with intoxication with perceptual disturbance, Cocaine use, unspecified with intoxication, unspecified, Cocaine use, unspecified with cocaine-induced mood disorder, Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions, Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations, Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified, Cocaine use, unspecified with cocaine-induced anxiety disorder, Cocaine use, unspecified with cocaine-induced sexual dysfunction, Cocaine use, unspecified with other cocaine-induced disorder, Cocaine use, unspecified with unspecified cocaine-induced disorder, Other stimulant abuse with intoxication, uncomplicated, Other stimulant abuse with intoxication delirium, Other stimulant abuse with intoxication with perceptual disturbance, Other stimulant abuse with intoxication, unspecified, Other stimulant abuse with stimulant-induced mood disorder, Other stimulant abuse with stimulant-induced psychotic disorder with delusions, Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations, Other stimulant abuse with stimulant-induced psychotic disorder, unspecified, Other stimulant abuse with stimulant-induced anxiety disorder, Other stimulant abuse with stimulant-induced sexual dysfunction, Other stimulant abuse with other stimulant-induced disorder, Other stimulant abuse with unspecified stimulant-induced disorder, Other stimulant dependence, uncomplicated, Other stimulant dependence with intoxication with perceptual disturbance, Other stimulant dependence with stimulant-induced psychotic disorder, unspecified, Other stimulant dependence with stimulant-induced anxiety disorder, Other stimulant dependence with stimulant-induced sexual dysfunction, Other stimulant dependence with other stimulant-induced disorder, Other stimulant use, unspecified, uncomplicated, Other stimulant use, unspecified with intoxication, uncomplicated, Other stimulant use, unspecified with intoxication delirium, Other stimulant use, unspecified with intoxication with perceptual disturbance, Other stimulant use, unspecified with intoxication, unspecified, Other stimulant use, unspecified with withdrawal, Other stimulant use, unspecified with stimulant-induced mood disorder, Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions, Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations, Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified, Other stimulant use, unspecified with stimulant-induced anxiety disorder, Other stimulant use, unspecified with stimulant-induced sexual dysfunction, Other stimulant use, unspecified with other stimulant-induced disorder, Other stimulant use, unspecified with unspecified stimulant-induced disorder, Hallucinogen abuse with intoxication, uncomplicated, Hallucinogen abuse with intoxication with delirium, Hallucinogen abuse with intoxication with perceptual disturbance, Hallucinogen abuse with intoxication, unspecified, Hallucinogen abuse with hallucinogen-induced mood disorder, Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions, Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations, Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified, Hallucinogen abuse with hallucinogen-induced anxiety disorder, Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks), Hallucinogen abuse with other hallucinogen-induced disorder, Hallucinogen abuse with unspecified hallucinogen-induced disorder, Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified, Hallucinogen dependence with hallucinogen-induced anxiety disorder, Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks), Hallucinogen dependence with other hallucinogen-induced disorder, Hallucinogen use, unspecified, uncomplicated, Hallucinogen use, unspecified with intoxication, uncomplicated, Hallucinogen use, unspecified with intoxication with delirium, Hallucinogen use, unspecified with intoxication, unspecified, Hallucinogen use, unspecified with hallucinogen-induced mood disorder, Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions, Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations, Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified, Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder, Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks), Hallucinogen use, unspecified with other hallucinogen-induced disorder, Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder, Nicotine dependence unspecified, with withdrawal, Nicotine dependence, unspecified, with other nicotine-induced disorders, Nicotine dependence, unspecified, with unspecified nicotine-induced disorders, Nicotine dependence, cigarettes, with withdrawal, Nicotine dependence, cigarettes, with other nicotine-induced disorders, Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders, Nicotine dependence, chewing tobacco, with withdrawal, Nicotine dependence, chewing tobacco, with other nicotine-induced disorders, Nicotine dependence, chewing tobacco, with unspecified nicotine-induced disorders, Nicotine dependence, other tobacco product, with withdrawal, Nicotine dependence, other tobacco product, with other nicotine-induced disorders, Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders, Inhalant abuse with intoxication, uncomplicated, Inhalant abuse with intoxication delirium, Inhalant abuse with intoxication, unspecified, Inhalant abuse with inhalant-induced mood disorder, Inhalant abuse with inhalant-induced psychotic disorder with delusions, Inhalant abuse with inhalant-induced psychotic disorder with hallucinations, Inhalant abuse with inhalant-induced psychotic disorder, unspecified, Inhalant abuse with inhalant-induced dementia, Inhalant abuse with inhalant-induced anxiety disorder, Inhalant abuse with other inhalant-induced disorder, Inhalant abuse with unspecified inhalant-induced disorder, Inhalant dependence with inhalant-induced psychotic disorder, unspecified, Inhalant dependence with inhalant-induced anxiety disorder, Inhalant dependence with other inhalant-induced disorder, Inhalant use, unspecified with intoxication, uncomplicated, Inhalant use, unspecified with intoxication with delirium, Inhalant use, unspecified with intoxication, unspecified, Inhalant use, unspecified with inhalant-induced mood disorder, Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions, Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations, Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified, Inhalant use, unspecified with inhalant-induced persisting dementia, Inhalant use, unspecified with inhalant-induced anxiety disorder, Inhalant use, unspecified with other inhalant-induced disorder, Inhalant use, unspecified with unspecified inhalant-induced disorder, Other psychoactive substance abuse, uncomplicated, Other psychoactive substance abuse with intoxication, uncomplicated, Other psychoactive substance abuse with intoxication delirium, Other psychoactive substance abuse with intoxication with perceptual disturbances, Other psychoactive substance abuse with intoxication, unspecified, Other psychoactive substance abuse with psychoactive substance-induced mood disorder, Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions, Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations, Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified, Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder, Other psychoactive substance abuse with psychoactive substance-induced persisting dementia, Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder, Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction, Other psychoactive substance abuse with other psychoactive substance-induced disorder, Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder, Other psychoactive substance dependence, uncomplicated, Other psychoactive substance dependence, in remission, Other psychoactive substance dependence with intoxication with perceptual disturbance, Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified, Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder, Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction, Other psychoactive substance dependence with other psychoactive substance-induced disorder, Other psychoactive substance use, unspecified, uncomplicated, Other psychoactive substance use, unspecified with intoxication, uncomplicated, Other psychoactive substance use, unspecified with intoxication with delirium, Other psychoactive substance use, unspecified with intoxication with perceptual disturbance, Other psychoactive substance use, unspecified with intoxication, unspecified, Other psychoactive substance use, unspecified with withdrawal, uncomplicated, Other psychoactive substance use, unspecified with withdrawal delirium, Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance, Other psychoactive substance use, unspecified with withdrawal, unspecified, Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder, Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions, Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations, Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified, Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder, Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia, Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder, Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction, Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder, Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder, Schizoaffective disorder, depressive type, Other psychotic disorder not due to a substance or known physiological condition, Unspecified psychosis not due to a substance or known physiological condition, Manic episode without psychotic symptoms, unspecified, Manic episode without psychotic symptoms, mild, Manic episode without psychotic symptoms, moderate, Manic episode, severe, without psychotic symptoms, Manic episode, severe with psychotic symptoms, Bipolar disorder, current episode hypomanic, Bipolar disorder, current episode manic without psychotic features, unspecified, Bipolar disorder, current episode manic without psychotic features, mild, Bipolar disorder, current episode manic without psychotic features, moderate, Bipolar disorder, current episode manic without psychotic features, severe, Bipolar disorder, current episode manic severe with psychotic features, Bipolar disorder, current episode depressed, mild or moderate severity, unspecified, Bipolar disorder, current episode depressed, mild, Bipolar disorder, current episode depressed, moderate, Bipolar disorder, current episode depressed, severe, without psychotic features, Bipolar disorder, current episode depressed, severe, with psychotic features, Bipolar disorder, current episode mixed, unspecified, Bipolar disorder, current episode mixed, mild, Bipolar disorder, current episode mixed, moderate, Bipolar disorder, current episode mixed, severe, without psychotic features, Bipolar disorder, current episode mixed, severe, with psychotic features, Bipolar disorder, currently in remission, most recent episode unspecified, Bipolar disorder, in partial remission, most recent episode hypomanic, Bipolar disorder, in full remission, most recent episode hypomanic, Bipolar disorder, in partial remission, most recent episode manic, Bipolar disorder, in partial remission, most recent episode depressed, Bipolar disorder, in partial remission, most recent episode mixed, Major depressive disorder, single episode, mild, Major depressive disorder, single episode, moderate, Major depressive disorder, single episode, severe without psychotic features, Major depressive disorder, single episode, severe with psychotic features, Major depressive disorder, single episode, in partial remission, Major depressive disorder, single episode, unspecified, Major depressive disorder, recurrent, mild, Major depressive disorder, recurrent, moderate, Major depressive disorder, recurrent severe without psychotic features, Major depressive disorder, recurrent, severe with psychotic symptoms, Major depressive disorder, recurrent, in remission, unspecified, Major depressive disorder, recurrent, in partial remission, Major depressive disorder, recurrent, unspecified, Other specified persistent mood disorders, Persistent mood [affective] disorder, unspecified, Panic disorder [episodic paroxysmal anxiety], Other dissociative and conversion disorders, Dissociative and conversion disorder, unspecified, Other genetic related intellectual disability, Other drug induced secondary parkinsonism, Secondary parkinsonism due to other external agents, Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus, Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus, Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus, Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus, Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus, Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus, Absence epileptic syndrome, not intractable, with status epilepticus, Absence epileptic syndrome, not intractable, without status epilepticus, Absence epileptic syndrome, intractable, with status epilepticus, Absence epileptic syndrome, intractable, without status epilepticus, Juvenile myoclonic epilepsy, not intractable, with status epilepticus, Juvenile myoclonic epilepsy, not intractable, without status epilepticus, Juvenile myoclonic epilepsy, intractable, with status epilepticus, Juvenile myoclonic epilepsy, intractable, without status epilepticus, Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus, Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus, Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus, Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus, Epileptic seizures related to external causes, not intractable, with status epilepticus, Epileptic seizures related to external causes, not intractable, without status epilepticus, Other epilepsy, not intractable, with status epilepticus, Other epilepsy, not intractable, without status epilepticus, Other epilepsy, intractable, with status epilepticus, Other epilepsy, intractable, without status epilepticus, Lennox-Gastaut syndrome, not intractable, with status epilepticus, Lennox-Gastaut syndrome, not intractable, without status epilepticus, Lennox-Gastaut syndrome, intractable, with status epilepticus, Lennox-Gastaut syndrome, intractable, without status epilepticus, Epileptic spasms, not intractable, with status epilepticus, Epileptic spasms, not intractable, without status epilepticus, Epileptic spasms, intractable, with status epilepticus, Epileptic spasms, intractable, without status epilepticus, Epilepsy, unspecified, not intractable, with status epilepticus, Epilepsy, unspecified, not intractable, without status epilepticus, Epilepsy, unspecified, intractable, with status epilepticus, Epilepsy, unspecified, intractable, without status epilepticus, Multiple and bilateral precerebral artery syndromes, Other transient cerebral ischemic attacks and related syndromes, Transient cerebral ischemic attack, unspecified, Other vascular syndromes of brain in cerebrovascular diseases, Obstructive sleep apnea (adult) (pediatric), Myasthenia gravis without (acute) exacerbation, Lambert-Eaton syndrome in disease classified elsewhere, Lambert-Eaton syndrome in neoplastic disease, Other intraoperative complications of nervous system, Other non-diabetic proliferative retinopathy, unspecified eye, Other non-diabetic proliferative retinopathy, right eye, Other non-diabetic proliferative retinopathy, left eye, Other non-diabetic proliferative retinopathy, bilateral, Exudative age-related macular degeneration, right eye, stage unspecified, Exudative age-related macular degeneration, right eye, with active choroidal neovascularization, Exudative age-related macular degeneration, right eye, with inactive choroidal neovascularization, Exudative age-related macular degeneration, right eye, with inactive scar, Exudative age-related macular degeneration, left eye, stage unspecified, Exudative age-related macular degeneration, left eye, with active choroidal neovascularization, Exudative age-related macular degeneration, left eye, with inactive choroidal neovascularization, Exudative age-related macular degeneration, left eye, with inactive scar, Exudative age-related macular degeneration, bilateral, stage unspecified, Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization, Exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization, Exudative age-related macular degeneration, bilateral, with inactive scar, Macular cyst, hole, or pseudohole, right eye, Macular cyst, hole, or pseudohole, left eye, Macular cyst, hole, or pseudohole, bilateral, Macular cyst, hole, or pseudohole, unspecified eye, Rheumatic mitral stenosis with insufficiency, Rheumatic mitral valve disease, unspecified, Rheumatic disorders of both mitral and tricuspid valves, Rheumatic disorders of both aortic and tricuspid valves, Combined rheumatic disorders of mitral, aortic and tricuspid valves, Rheumatic multiple valve disease, unspecified, Rheumatic diseases of endocardium, valve unspecified, Hypertensive heart disease with heart failure, Hypertensive heart disease without heart failure, Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease, Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease, Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease, Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease, Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease, Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease, Hypertension secondary to other renal disorders, ST elevation (STEMI) myocardial infarction involving left main coronary artery, ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery, ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall, ST elevation (STEMI) myocardial infarction involving right coronary artery, ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall, ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery, ST elevation (STEMI) myocardial infarction involving other sites, ST elevation (STEMI) myocardial infarction of unspecified site, Non-ST elevation (NSTEMI) myocardial infarction, Subsequent ST elevation (STEMI) myocardial infarction of anterior wall, Subsequent ST elevation (STEMI) myocardial infarction of inferior wall, Subsequent non-ST elevation (NSTEMI) myocardial infarction, Subsequent ST elevation (STEMI) myocardial infarction of other sites, Subsequent ST elevation (STEMI) myocardial infarction of unspecified site, Acute coronary thrombosis not resulting in myocardial infarction, Other forms of acute ischemic heart disease, Acute ischemic heart disease, unspecified, Atherosclerotic heart disease of native coronary artery without angina pectoris, Atherosclerotic heart disease of native coronary artery with unstable angina pectoris, Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm, Atherosclerosic heart disease of native coronary artery with refractory angina pectoris, Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris, Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris, Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris, Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm, Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris, Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris, Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris, Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm, Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris, Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris, Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris, Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris, Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm, Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris, Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris, Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris, Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris, Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm, Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris, Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris, Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris, Atherosclerosis of native coronary artery of transplanted heart with unstable angina, Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm, Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris, Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris, Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris, Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina, Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm, Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris, Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris, Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris, Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris, Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm, Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris, Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris, Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris, Atherosclerosis of coronary artery bypass graft(s) without angina pectoris, Atherosclerosis of native coronary artery of transplanted heart without angina pectoris, Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris, Chronic total occlusion of coronary artery, Coronary atherosclerosis due to lipid rich plaque, Coronary atherosclerosis due to calcified coronary lesion, Other forms of chronic ischemic heart disease, Chronic ischemic heart disease, unspecified, Other pulmonary embolism with acute cor pulmonale, Acute nonspecific idiopathic pericarditis, Hemopericardium, not elsewhere classified, Malignant pericardial effusion in diseases classified elsewhere, Other pericardial effusion (noninflammatory), Pericarditis in diseases classified elsewhere, Acute and subacute infective endocarditis, Acute and subacute endocarditis, unspecified, Nonrheumatic mitral (valve) insufficiency, Nonrheumatic mitral (valve) annulus calcification, Other nonrheumatic mitral valve disorders, Nonrheumatic mitral valve disorder, unspecified, Nonrheumatic aortic (valve) insufficiency, Nonrheumatic aortic (valve) stenosis with insufficiency, Other nonrheumatic aortic valve disorders, Nonrheumatic aortic valve disorder, unspecified, Nonrheumatic tricuspid (valve) insufficiency, Nonrheumatic tricuspid (valve) stenosis with insufficiency, Other nonrheumatic tricuspid valve disorders, Nonrheumatic tricuspid valve disorder, unspecified, Nonrheumatic pulmonary valve insufficiency, Nonrheumatic pulmonary valve stenosis with insufficiency, Other nonrheumatic pulmonary valve disorders, Nonrheumatic pulmonary valve disorder, unspecified, Endocarditis and heart valve disorders in diseases classified elsewhere, Myocarditis in diseases classified elsewhere, Cardiomyopathy due to drug and external agent, Cardiomyopathy in diseases classified elsewhere, Cardiac arrest due to underlying cardiac condition, Cardiac arrest due to other underlying condition, Longstanding persistent atrial fibrillation, Unspecified systolic (congestive) heart failure, Acute systolic (congestive) heart failure, Chronic systolic (congestive) heart failure, Acute on chronic systolic (congestive) heart failure, Unspecified diastolic (congestive) heart failure, Acute diastolic (congestive) heart failure, Chronic diastolic (congestive) heart failure, Acute on chronic diastolic (congestive) heart failure, Unspecified combined systolic (congestive) and diastolic (congestive) heart failure, Acute combined systolic (congestive) and diastolic (congestive) heart failure, Chronic combined systolic (congestive) and diastolic (congestive) heart failure, Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure, Right heart failure due to left heart failure, Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation, Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation, Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation, Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery, Nontraumatic subarachnoid hemorrhage from right middle cerebral artery, Nontraumatic subarachnoid hemorrhage from left middle cerebral artery, Nontraumatic subarachnoid hemorrhage from anterior communicating artery, Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery, Nontraumatic subarachnoid hemorrhage from right posterior communicating artery, Nontraumatic subarachnoid hemorrhage from left posterior communicating artery, Nontraumatic subarachnoid hemorrhage from basilar artery, Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery, Nontraumatic subarachnoid hemorrhage from right vertebral artery, Nontraumatic subarachnoid hemorrhage from left vertebral artery, Nontraumatic subarachnoid hemorrhage from other intracranial arteries, Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery, Other nontraumatic subarachnoid hemorrhage, Nontraumatic subarachnoid hemorrhage, unspecified, Nontraumatic intracerebral hemorrhage in hemisphere, subcortical, Nontraumatic intracerebral hemorrhage in hemisphere, cortical, Nontraumatic intracerebral hemorrhage in hemisphere, unspecified, Nontraumatic intracerebral hemorrhage in brain stem, Nontraumatic intracerebral hemorrhage in cerebellum, Nontraumatic intracerebral hemorrhage, intraventricular, Nontraumatic intracerebral hemorrhage, multiple localized, Other nontraumatic intracerebral hemorrhage, Nontraumatic intracerebral hemorrhage, unspecified, Nontraumatic subdural hemorrhage, unspecified, Nontraumatic subacute subdural hemorrhage, Cerebral infarction due to thrombosis of unspecified precerebral artery, Cerebral infarction due to thrombosis of right vertebral artery, Cerebral infarction due to thrombosis of left vertebral artery, Cerebral infarction due to thrombosis of bilateral vertebral arteries, Cerebral infarction due to thrombosis of unspecified vertebral artery, Cerebral infarction due to thrombosis of basilar artery, Cerebral infarction due to thrombosis of right carotid artery, Cerebral infarction due to thrombosis of left carotid artery, Cerebral infarction due to thrombosis of bilateral carotid arteries, Cerebral infarction due to thrombosis of unspecified carotid artery, Cerebral infarction due to thrombosis of other precerebral artery, Cerebral infarction due to embolism of unspecified precerebral artery, Cerebral infarction due to embolism of right vertebral artery, Cerebral infarction due to embolism of left vertebral artery, Cerebral infarction due to embolism of bilateral vertebral arteries, Cerebral infarction due to embolism of unspecified vertebral artery, Cerebral infarction due to embolism of basilar artery, Cerebral infarction due to embolism of right carotid artery, Cerebral infarction due to embolism of left carotid artery, Cerebral infarction due to embolism of bilateral carotid arteries, Cerebral infarction due to embolism of unspecified carotid artery, Cerebral infarction due to embolism of other precerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries, Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery, Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery, Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries, Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery, Cerebral infarction due to unspecified occlusion or stenosis of basilar artery, Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries, Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries, Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries, Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery, Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries, Cerebral infarction due to thrombosis of unspecified cerebral artery, Cerebral infarction due to thrombosis of right middle cerebral artery, Cerebral infarction due to thrombosis of left middle cerebral artery, Cerebral infarction due to thrombosis of bilateral middle cerebral arteries, Cerebral infarction due to thrombosis of unspecified middle cerebral artery, Cerebral infarction due to thrombosis of right anterior cerebral artery, Cerebral infarction due to thrombosis of left anterior cerebral artery, Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries, Cerebral infarction due to thrombosis of unspecified anterior cerebral artery, Cerebral infarction due to thrombosis of right posterior cerebral artery, Cerebral infarction due to thrombosis of left posterior cerebral artery, Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries, Cerebral infarction due to thrombosis of unspecified posterior cerebral artery, Cerebral infarction due to thrombosis of right cerebellar artery, Cerebral infarction due to thrombosis of left cerebellar artery, Cerebral infarction due to thrombosis of bilateral cerebellar arteries, Cerebral infarction due to thrombosis of unspecified cerebellar artery, Cerebral infarction due to thrombosis of other cerebral artery, Cerebral infarction due to embolism of unspecified cerebral artery, Cerebral infarction due to embolism of right middle cerebral artery, Cerebral infarction due to embolism of left middle cerebral artery, Cerebral infarction due to embolism of bilateral middle cerebral arteries, Cerebral infarction due to embolism of unspecified middle cerebral artery, Cerebral infarction due to embolism of right anterior cerebral artery, Cerebral infarction due to embolism of left anterior cerebral artery, Cerebral infarction due to embolism of bilateral anterior cerebral arteries, Cerebral infarction due to embolism of unspecified anterior cerebral artery, Cerebral infarction due to embolism of right posterior cerebral artery, Cerebral infarction due to embolism of left posterior cerebral artery, Cerebral infarction due to embolism of bilateral posterior cerebral arteries, Cerebral infarction due to embolism of unspecified posterior cerebral artery, Cerebral infarction due to embolism of right cerebellar artery, Cerebral infarction due to embolism of left cerebellar artery, Cerebral infarction due to embolism of bilateral cerebellar arteries, Cerebral infarction due to embolism of unspecified cerebellar artery, Cerebral infarction due to embolism of other cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries, Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries, Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries, Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery, Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery, Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery, Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries, Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery, Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery, Cerebral infarction due to cerebral venous thrombosis, nonpyogenic, Other cerebral infarction due to occlusion or stenosis of small artery, Occlusion and stenosis of right vertebral artery, Occlusion and stenosis of left vertebral artery, Occlusion and stenosis of bilateral vertebral arteries, Occlusion and stenosis of unspecified vertebral artery, Occlusion and stenosis of right carotid artery, Occlusion and stenosis of left carotid artery, Occlusion and stenosis of bilateral carotid arteries, Occlusion and stenosis of unspecified carotid artery, Occlusion and stenosis of other precerebral arteries, Occlusion and stenosis of unspecified precerebral artery, Occlusion and stenosis of right middle cerebral artery, Occlusion and stenosis of left middle cerebral artery, Occlusion and stenosis of bilateral middle cerebral arteries, Occlusion and stenosis of unspecified middle cerebral artery, Occlusion and stenosis of right anterior cerebral artery, Occlusion and stenosis of left anterior cerebral artery, Occlusion and stenosis of bilateral anterior cerebral arteries, Occlusion and stenosis of unspecified anterior cerebral artery, Occlusion and stenosis of right posterior cerebral artery, Occlusion and stenosis of left posterior cerebral artery, Occlusion and stenosis of bilateral posterior cerebral arteries, Occlusion and stenosis of unspecified posterior cerebral artery, Occlusion and stenosis of cerebellar arteries, Occlusion and stenosis of other cerebral arteries, Occlusion and stenosis of unspecified cerebral artery, Nonpyogenic thrombosis of intracranial venous system, Cerebral arteritis, not elsewhere classified, Reversible cerebrovascular vasoconstriction syndrome, Other cerebrovascular vasospasm and vasoconstriction, Cerebral arteritis in other diseases classified elsewhere, Other cerebrovascular disorders in diseases classified elsewhere, Bronchitis, not specified as acute or chronic, Unilateral pulmonary emphysema [MacLeod's syndrome], Chronic obstructive pulmonary disease, unspecified, Pneumoconiosis due to asbestos and other mineral fibers, Pneumoconiosis due to other dust containing silica, Pneumoconiosis due to other specified inorganic dusts, Pneumoconiosis associated with tuberculosis, Airway disease due to other specific organic dusts, Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors, Pulmonary edema due to chemicals, gases, fumes and vapors, Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified, Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors, Chronic respiratory conditions due to chemicals, gases, fumes and vapors, Other respiratory conditions due to chemicals, gases, fumes and vapors, Unspecified respiratory condition due to chemicals, gases, fumes and vapors, Acute pulmonary manifestations due to radiation, Chronic and other pulmonary manifestations due to radiation, Acute drug-induced interstitial lung disorders, Chronic drug-induced interstitial lung disorders, Drug-induced interstitial lung disorders, unspecified, Respiratory conditions due to smoke inhalation, Respiratory conditions due to other specified external agents, Respiratory conditions due to unspecified external agent, Other pulmonary eosinophilia, not elsewhere classified, Pleural effusion, not elsewhere classified, Pleural effusion in other conditions classified elsewhere, Acute pulmonary insufficiency following thoracic surgery, Acute pulmonary insufficiency following nonthoracic surgery, Chronic pulmonary insufficiency following surgery, Acute and chronic postprocedural respiratory failure, Transfusion-related acute lung injury (TRALI), Acute respiratory failure, unspecified whether with hypoxia or hypercapnia, Acute respiratory failure with hypercapnia, Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia, Acute and chronic respiratory failure with hypoxia, Acute and chronic respiratory failure with hypercapnia, Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia, Respiratory failure, unspecified with hypoxia, Respiratory failure, unspecified with hypercapnia, Alcoholic fibrosis and sclerosis of liver, Alcoholic cirrhosis of liver without ascites, Alcoholic cirrhosis of liver with ascites, Acute and subacute hepatic failure without coma, Hepatic failure, unspecified without coma, Chronic persistent hepatitis, not elsewhere classified, Chronic lobular hepatitis, not elsewhere classified, Chronic active hepatitis, not elsewhere classified, Other chronic hepatitis, not elsewhere classified, Fatty (change of) liver, not elsewhere classified, Idiopathic acute pancreatitis without necrosis or infection, Idiopathic acute pancreatitis with uninfected necrosis, Idiopathic acute pancreatitis with infected necrosis, Biliary acute pancreatitis without necrosis or infection, Biliary acute pancreatitis with uninfected necrosis, Biliary acute pancreatitis with infected necrosis, Alcohol induced acute pancreatitis without necrosis or infection, Alcohol induced acute pancreatitis with uninfected necrosis, Alcohol induced acute pancreatitis with infected necrosis, Drug induced acute pancreatitis without necrosis or infection, Drug induced acute pancreatitis with uninfected necrosis, Drug induced acute pancreatitis with infected necrosis, Other acute pancreatitis without necrosis or infection, Other acute pancreatitis with uninfected necrosis, Other acute pancreatitis with infected necrosis, Acute pancreatitis without necrosis or infection, unspecified, Acute pancreatitis with uninfected necrosis, unspecified, Acute pancreatitis with infected necrosis, unspecified, Acute kidney failure with tubular necrosis, Acute kidney failure with acute cortical necrosis, Acute kidney failure with medullary necrosis, Superior sinus venosus atrial septal defect, Inferior sinus venosus atrial septal defect, Sinus venosus atrial septal defect, unspecified, Adverse effect of penicillins, initial encounter, Adverse effect of penicillins, subsequent encounter, Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter, Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter, Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela, Adverse effect of chloramphenicol group, initial encounter, Adverse effect of chloramphenicol group, subsequent encounter, Adverse effect of chloramphenicol group, sequela, Adverse effect of macrolides, initial encounter, Adverse effect of macrolides, subsequent encounter, Adverse effect of tetracyclines, initial encounter, Adverse effect of tetracyclines, subsequent encounter, Adverse effect of aminoglycosides, initial encounter, Adverse effect of aminoglycosides, subsequent encounter, Adverse effect of aminoglycosides, sequela, Adverse effect of rifampicins, initial encounter, Adverse effect of rifampicins, subsequent encounter, Adverse effect of antifungal antibiotics, systemically used, initial encounter, Adverse effect of antifungal antibiotics, systemically used, subsequent encounter, Adverse effect of antifungal antibiotics, systemically used, sequela, Adverse effect of other systemic antibiotics, initial encounter, Adverse effect of other systemic antibiotics, subsequent encounter, Adverse effect of other systemic antibiotics, sequela, Adverse effect of unspecified systemic antibiotic, initial encounter, Adverse effect of unspecified systemic antibiotic, subsequent encounter, Adverse effect of unspecified systemic antibiotic, sequela, Adverse effect of sulfonamides, initial encounter, Adverse effect of sulfonamides, subsequent encounter, Adverse effect of antimycobacterial drugs, initial encounter, Adverse effect of antimycobacterial drugs, subsequent encounter, Adverse effect of antimycobacterial drugs, sequela, Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter, Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter, Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela, Adverse effect of other antiprotozoal drugs, initial encounter, Adverse effect of other antiprotozoal drugs, subsequent encounter, Adverse effect of other antiprotozoal drugs, sequela, Adverse effect of anthelminthics, initial encounter, Adverse effect of anthelminthics, subsequent encounter, Adverse effect of anthelminthics, sequela, Adverse effect of antiviral drugs, initial encounter, Adverse effect of antiviral drugs, subsequent encounter, Adverse effect of antiviral drugs, sequela, Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter, Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter, Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela, Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter, Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter, Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela, Adverse effect of glucocorticoids and synthetic analogues, initial encounter, Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter, Adverse effect of glucocorticoids and synthetic analogues, sequela, Adverse effect of thyroid hormones and substitutes, initial encounter, Adverse effect of thyroid hormones and substitutes, subsequent encounter, Adverse effect of thyroid hormones and substitutes, sequela, Adverse effect of antithyroid drugs, initial encounter, Adverse effect of antithyroid drugs, subsequent encounter, Adverse effect of antithyroid drugs, sequela, Adverse effect of oral contraceptives, initial encounter, Adverse effect of oral contraceptives, subsequent encounter, Adverse effect of oral contraceptives, sequela, Adverse effect of other estrogens and progestogens, initial encounter, Adverse effect of other estrogens and progestogens, subsequent encounter, Adverse effect of other estrogens and progestogens, sequela, Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter, Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter, Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela, Adverse effect of androgens and anabolic congeners, initial encounter, Adverse effect of androgens and anabolic congeners, subsequent encounter, Adverse effect of androgens and anabolic congeners, sequela, Adverse effect of unspecified hormones and synthetic substitutes, initial encounter, Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter, Adverse effect of unspecified hormones and synthetic substitutes, sequela, Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter, Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter, Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela, Adverse effect of other hormones and synthetic substitutes, initial encounter, Adverse effect of other hormones and synthetic substitutes, subsequent encounter, Adverse effect of other hormones and synthetic substitutes, sequela, Adverse effect of unspecified hormone antagonists, initial encounter, Adverse effect of unspecified hormone antagonists, subsequent encounter, Adverse effect of unspecified hormone antagonists, sequela, Adverse effect of other hormone antagonists, initial encounter, Adverse effect of other hormone antagonists, subsequent encounter, Adverse effect of other hormone antagonists, sequela, Adverse effect of aspirin, initial encounter, Adverse effect of aspirin, subsequent encounter, Adverse effect of salicylates, initial encounter, Adverse effect of salicylates, subsequent encounter, Adverse effect of 4-Aminophenol derivatives, initial encounter, Adverse effect of 4-Aminophenol derivatives, subsequent encounter, Adverse effect of 4-Aminophenol derivatives, sequela, Adverse effect of pyrazolone derivatives, initial encounter, Adverse effect of pyrazolone derivatives, subsequent encounter, Adverse effect of pyrazolone derivatives, sequela, Adverse effect of propionic acid derivatives, initial encounter, Adverse effect of propionic acid derivatives, subsequent encounter, Adverse effect of propionic acid derivatives, sequela, Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter, Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter, Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela, Adverse effect of antirheumatics, not elsewhere classified, initial encounter, Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter, Adverse effect of antirheumatics, not elsewhere classified, sequela, Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter, Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter, Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela, Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter, Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter, Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela, Adverse effect of opium, initial encounter, Adverse effect of opium, subsequent encounter, Adverse effect of other opioids, initial encounter, Adverse effect of other opioids, subsequent encounter, Adverse effect of methadone, initial encounter, Adverse effect of methadone, subsequent encounter, Adverse effect of other synthetic narcotics, initial encounter, Adverse effect of other synthetic narcotics, subsequent encounter, Adverse effect of other synthetic narcotics, sequela, Adverse effect of cocaine, initial encounter, Adverse effect of cocaine, subsequent encounter, Adverse effect of unspecified narcotics, initial encounter, Adverse effect of unspecified narcotics, subsequent encounter, Adverse effect of unspecified narcotics, sequela, Adverse effect of other narcotics, initial encounter, Adverse effect of other narcotics, subsequent encounter, Adverse effect of other narcotics, sequela, Adverse effect of cannabis, initial encounter, Adverse effect of cannabis, subsequent encounter, Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter, Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter, Adverse effect of unspecified psychodysleptics [hallucinogens], sequela, Adverse effect of other psychodysleptics [hallucinogens], initial encounter, Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter, Adverse effect of other psychodysleptics [hallucinogens], sequela, Adverse effect of inhaled anesthetics, initial encounter, Adverse effect of inhaled anesthetics, subsequent encounter, Adverse effect of inhaled anesthetics, sequela, Adverse effect of intravenous anesthetics, initial encounter, Adverse effect of intravenous anesthetics, subsequent encounter, Adverse effect of intravenous anesthetics, sequela, Adverse effect of unspecified general anesthetics, initial encounter, Adverse effect of unspecified general anesthetics, subsequent encounter, Adverse effect of unspecified general anesthetics, sequela, Adverse effect of other general anesthetics, initial encounter, Adverse effect of other general anesthetics, subsequent encounter, Adverse effect of other general anesthetics, sequela, Adverse effect of local anesthetics, initial encounter, Adverse effect of local anesthetics, subsequent encounter, Adverse effect of local anesthetics, sequela, Adverse effect of unspecified anesthetic, initial encounter, Adverse effect of unspecified anesthetic, subsequent encounter, Adverse effect of unspecified anesthetic, sequela, Adverse effect of therapeutic gases, initial encounter, Adverse effect of therapeutic gases, subsequent encounter, Adverse effect of therapeutic gases, sequela, Adverse effect of hydantoin derivatives, initial encounter, Adverse effect of hydantoin derivatives, subsequent encounter, Adverse effect of hydantoin derivatives, sequela, Adverse effect of iminostilbenes, initial encounter, Adverse effect of iminostilbenes, subsequent encounter, Adverse effect of iminostilbenes, sequela, Adverse effect of succinimides and oxazolidinediones, initial encounter, Adverse effect of succinimides and oxazolidinediones, subsequent encounter, Adverse effect of succinimides and oxazolidinediones, sequela, Adverse effect of barbiturates, initial encounter, Adverse effect of barbiturates, subsequent encounter, Adverse effect of benzodiazepines, initial encounter, Adverse effect of benzodiazepines, subsequent encounter, Adverse effect of benzodiazepines, sequela, Adverse effect of mixed antiepileptics, initial encounter, Adverse effect of mixed antiepileptics, subsequent encounter, Adverse effect of mixed antiepileptics, sequela, Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter, Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter, Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela, Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter, Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter, Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela, Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter, Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter, Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela, Adverse effect of tricyclic antidepressants, initial encounter, Adverse effect of tricyclic antidepressants, subsequent encounter, Adverse effect of tricyclic antidepressants, sequela, Adverse effect of tetracyclic antidepressants, initial encounter, Adverse effect of tetracyclic antidepressants, subsequent encounter, Adverse effect of tetracyclic antidepressants, sequela, Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter, Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter, Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela, Adverse effect of unspecified antidepressants, initial encounter, Adverse effect of unspecified antidepressants, subsequent encounter, Adverse effect of unspecified antidepressants, sequela, Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter, Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter, Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela, Adverse effect of selective serotonin reuptake inhibitors, initial encounter, Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter, Adverse effect of selective serotonin reuptake inhibitors, sequela, Adverse effect of other antidepressants, initial encounter, Adverse effect of other antidepressants, subsequent encounter, Adverse effect of other antidepressants, sequela, Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter, Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter, Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela, Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter, Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter, Adverse effect of butyrophenone and thiothixene neuroleptics, sequela, Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter, Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter, Adverse effect of unspecified antipsychotics and neuroleptics, sequela, Adverse effect of other antipsychotics and neuroleptics, initial encounter, Adverse effect of other antipsychotics and neuroleptics, subsequent encounter, Adverse effect of other antipsychotics and neuroleptics, sequela, Adverse effect of unspecified psychostimulants, initial encounter, Adverse effect of unspecified psychostimulants, subsequent encounter, Adverse effect of unspecified psychostimulants, sequela, Adverse effect of caffeine, initial encounter, Adverse effect of caffeine, subsequent encounter, Adverse effect of amphetamines, initial encounter, Adverse effect of amphetamines, subsequent encounter, Adverse effect of methylphenidate, initial encounter, Adverse effect of methylphenidate, subsequent encounter, Adverse effect of methylphenidate, sequela, Adverse effect of other psychostimulants, initial encounter, Adverse effect of other psychostimulants, subsequent encounter, Adverse effect of other psychostimulants, sequela, Adverse effect of other psychotropic drugs, initial encounter, Adverse effect of other psychotropic drugs, subsequent encounter, Adverse effect of other psychotropic drugs, sequela, Adverse effect of unspecified psychotropic drug, initial encounter, Adverse effect of unspecified psychotropic drug, subsequent encounter, Adverse effect of unspecified psychotropic drug, sequela, Adverse effect of anticholinesterase agents, initial encounter, Adverse effect of anticholinesterase agents, subsequent encounter, Adverse effect of anticholinesterase agents, sequela, Adverse effect of other parasympathomimetics [cholinergics], initial encounter, Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter, Adverse effect of other parasympathomimetics [cholinergics], sequela, Adverse effect of ganglionic blocking drugs, initial encounter, Adverse effect of ganglionic blocking drugs, subsequent encounter, Adverse effect of ganglionic blocking drugs, sequela, Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter, Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter, Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela, Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter, Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter, Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela, Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter, Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter, Adverse effect of predominantly beta-adrenoreceptor agonists, sequela, Adverse effect of alpha-adrenoreceptor antagonists, initial encounter, Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter, Adverse effect of alpha-adrenoreceptor antagonists, sequela, Adverse effect of beta-adrenoreceptor antagonists, initial encounter, Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter, Adverse effect of beta-adrenoreceptor antagonists, sequela, Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter, Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter, Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela, Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter, Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter, Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela, Adverse effect of antiallergic and antiemetic drugs, initial encounter, Adverse effect of antiallergic and antiemetic drugs, subsequent encounter, Adverse effect of antiallergic and antiemetic drugs, sequela, Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter, Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter, Adverse effect of antineoplastic and immunosuppressive drugs, sequela, Adverse effect of vitamins, initial encounter, Adverse effect of vitamins, subsequent encounter, Adverse effect of enzymes, initial encounter, Adverse effect of enzymes, subsequent encounter, Adverse effect of iron and its compounds, initial encounter, Adverse effect of iron and its compounds, subsequent encounter, Adverse effect of iron and its compounds, sequela, Adverse effect of anticoagulants, initial encounter, Adverse effect of anticoagulants, subsequent encounter, Adverse effect of anticoagulants, sequela, Adverse effect of antithrombotic drugs, initial encounter, Adverse effect of antithrombotic drugs, subsequent encounter, Adverse effect of antithrombotic drugs, sequela, Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter, Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter, Adverse effect of unspecified fibrinolysis-affecting drugs, sequela, Adverse effect of thrombolytic drugs, initial encounter, Adverse effect of thrombolytic drugs, subsequent encounter, Adverse effect of thrombolytic drugs, sequela, Adverse effect of hemostatic drug, initial encounter, Adverse effect of hemostatic drug, subsequent encounter, Adverse effect of hemostatic drug, sequela, Adverse effect of other fibrinolysis-affecting drugs, initial encounter, Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter, Adverse effect of other fibrinolysis-affecting drugs, sequela, Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter, Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter, Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela, Adverse effect of other primarily systemic and hematological agents, initial encounter, Adverse effect of other primarily systemic and hematological agents, subsequent encounter, Adverse effect of other primarily systemic and hematological agents, sequela, Adverse effect of unspecified primarily systemic and hematological agent, initial encounter, Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter, Adverse effect of unspecified primarily systemic and hematological agent, sequela, Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter, Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter, Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela, Adverse effect of calcium-channel blockers, initial encounter, Adverse effect of calcium-channel blockers, subsequent encounter, Adverse effect of calcium-channel blockers, sequela, Adverse effect of other antidysrhythmic drugs, initial encounter, Adverse effect of other antidysrhythmic drugs, subsequent encounter, Adverse effect of other antidysrhythmic drugs, sequela, Adverse effect of coronary vasodilators, initial encounter, Adverse effect of coronary vasodilators, subsequent encounter, Adverse effect of coronary vasodilators, sequela, Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter, Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter, Adverse effect of angiotensin-converting-enzyme inhibitors, sequela, Adverse effect of other antihypertensive drugs, initial encounter, Adverse effect of other antihypertensive drugs, subsequent encounter, Adverse effect of other antihypertensive drugs, sequela, Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter, Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter, Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela, Adverse effect of peripheral vasodilators, initial encounter, Adverse effect of peripheral vasodilators, subsequent encounter, Adverse effect of peripheral vasodilators, sequela, Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter, Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter, Adverse effect of antivaricose drugs, including sclerosing agents, sequela, Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter, Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter, Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela, Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter, Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter, Adverse effect of other agents primarily affecting the cardiovascular system, sequela, Adverse effect of histamine H2-receptor blockers, initial encounter, Adverse effect of histamine H2-receptor blockers, subsequent encounter, Adverse effect of histamine H2-receptor blockers, sequela, Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter, Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter, Adverse effect of other antacids and anti-gastric-secretion drugs, sequela, Adverse effect of stimulant laxatives, initial encounter, Adverse effect of stimulant laxatives, subsequent encounter, Adverse effect of stimulant laxatives, sequela, Adverse effect of saline and osmotic laxatives, initial encounter, Adverse effect of saline and osmotic laxatives, subsequent encounter, Adverse effect of saline and osmotic laxatives, sequela, Adverse effect of other laxatives, initial encounter, Adverse effect of other laxatives, subsequent encounter, Adverse effect of other laxatives, sequela, Adverse effect of digestants, initial encounter, Adverse effect of digestants, subsequent encounter, Adverse effect of antidiarrheal drugs, initial encounter, Adverse effect of antidiarrheal drugs, subsequent encounter, Adverse effect of antidiarrheal drugs, sequela, Adverse effect of emetics, initial encounter, Adverse effect of emetics, subsequent encounter, Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter, Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter, Adverse effect of other agents primarily affecting gastrointestinal system, sequela, Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter, Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter, Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela, Adverse effect of oxytocic drugs, initial encounter, Adverse effect of oxytocic drugs, subsequent encounter, Adverse effect of oxytocic drugs, sequela, Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter, Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter, Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela, Adverse effect of unspecified drugs acting on muscles, initial encounter, Adverse effect of unspecified drugs acting on muscles, subsequent encounter, Adverse effect of unspecified drugs acting on muscles, sequela, Adverse effect of other drugs acting on muscles, initial encounter, Adverse effect of other drugs acting on muscles, subsequent encounter, Adverse effect of other drugs acting on muscles, sequela, Adverse effect of antitussives, initial encounter, Adverse effect of antitussives, subsequent encounter, Adverse effect of expectorants, initial encounter, Adverse effect of expectorants, subsequent encounter, Adverse effect of other anti-common-cold drugs, initial encounter, Adverse effect of other anti-common-cold drugs, subsequent encounter, Adverse effect of other anti-common-cold drugs, sequela, Adverse effect of antiasthmatics, initial encounter, Adverse effect of antiasthmatics, subsequent encounter, Adverse effect of antiasthmatics, sequela, Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter, Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter, Adverse effect of unspecified agents primarily acting on the respiratory system, sequela, Adverse effect of other agents primarily acting on the respiratory system, initial encounter, Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter, Adverse effect of other agents primarily acting on the respiratory system, sequela, Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter, Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter, Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela, Adverse effect of antipruritics, initial encounter, Adverse effect of antipruritics, subsequent encounter, Adverse effect of local astringents and local detergents, initial encounter, Adverse effect of local astringents and local detergents, subsequent encounter, Adverse effect of local astringents and local detergents, sequela, Adverse effect of emollients, demulcents and protectants, initial encounter, Adverse effect of emollients, demulcents and protectants, subsequent encounter, Adverse effect of emollients, demulcents and protectants, sequela, Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter, Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter, Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela, Adverse effect of ophthalmological drugs and preparations, initial encounter, Adverse effect of ophthalmological drugs and preparations, subsequent encounter, Adverse effect of ophthalmological drugs and preparations, sequela, Adverse effect of otorhinolaryngological drugs and preparations, initial encounter, Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter, Adverse effect of otorhinolaryngological drugs and preparations, sequela, Adverse effect of dental drugs, topically applied, initial encounter, Adverse effect of dental drugs, topically applied, subsequent encounter, Adverse effect of dental drugs, topically applied, sequela, Adverse effect of other topical agents, initial encounter, Adverse effect of other topical agents, subsequent encounter, Adverse effect of other topical agents, sequela, Adverse effect of unspecified topical agent, initial encounter, Adverse effect of unspecified topical agent, subsequent encounter, Adverse effect of unspecified topical agent, sequela, Adverse effect of mineralocorticoids and their antagonists, initial encounter, Adverse effect of mineralocorticoids and their antagonists, subsequent encounter, Adverse effect of mineralocorticoids and their antagonists, sequela, Adverse effect of loop [high-ceiling] diuretics, initial encounter, Adverse effect of loop [high-ceiling] diuretics, subsequent encounter, Adverse effect of loop [high-ceiling] diuretics, sequela, Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter, Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter, Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela, Adverse effect of electrolytic, caloric and water-balance agents, initial encounter, Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter, Adverse effect of electrolytic, caloric and water-balance agents, sequela, Adverse effect of drugs affecting uric acid metabolism, initial encounter, Adverse effect of drugs affecting uric acid metabolism, subsequent encounter, Adverse effect of drugs affecting uric acid metabolism, sequela, Adverse effect of appetite depressants, initial encounter, Adverse effect of appetite depressants, subsequent encounter, Adverse effect of appetite depressants, sequela, Adverse effect of antidotes and chelating agents, initial encounter, Adverse effect of antidotes and chelating agents, subsequent encounter, Adverse effect of antidotes and chelating agents, sequela, Adverse effect of analeptics and opioid receptor antagonists, initial encounter, Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter, Adverse effect of analeptics and opioid receptor antagonists, sequela, Adverse effect of diagnostic agents, initial encounter, Adverse effect of diagnostic agents, subsequent encounter, Adverse effect of diagnostic agents, sequela, Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter, Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter, Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela, Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter, Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter, Adverse effect of mixed bacterial vaccines without a pertussis component, sequela, Adverse effect of other bacterial vaccines, initial encounter, Adverse effect of other bacterial vaccines, subsequent encounter, Adverse effect of other bacterial vaccines, sequela, Adverse effect of smallpox vaccines, initial encounter, Adverse effect of smallpox vaccines, subsequent encounter, Adverse effect of smallpox vaccines, sequela, Adverse effect of other viral vaccines, initial encounter, Adverse effect of other viral vaccines, subsequent encounter, Adverse effect of other viral vaccines, sequela, Adverse effect of immunoglobulin, initial encounter, Adverse effect of immunoglobulin, subsequent encounter, Adverse effect of immunoglobulin, sequela, Adverse effect of other vaccines and biological substances, initial encounter, Adverse effect of other vaccines and biological substances, subsequent encounter, Adverse effect of other vaccines and biological substances, sequela, Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter, Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter, Adverse effect of unspecified drugs, medicaments and biological substances, sequela, Adverse effect of other drugs, medicaments and biological substances, initial encounter, Adverse effect of other drugs, medicaments and biological substances, subsequent encounter, Adverse effect of other drugs, medicaments and biological substances, sequela, Anaphylactic reaction due to unspecified food, initial encounter, Anaphylactic reaction due to unspecified food, subsequent encounter, Anaphylactic reaction due to unspecified food, sequela, Anaphylactic reaction due to peanuts, initial encounter, Anaphylactic reaction due to peanuts, subsequent encounter, Anaphylactic reaction due to peanuts, sequela, Anaphylactic reaction due to shellfish (crustaceans), initial encounter, Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter, Anaphylactic reaction due to shellfish (crustaceans), sequela, Anaphylactic reaction due to other fish, initial encounter, Anaphylactic reaction due to other fish, subsequent encounter, Anaphylactic reaction due to other fish, sequela, Anaphylactic reaction due to fruits and vegetables, initial encounter, Anaphylactic reaction due to fruits and vegetables, subsequent encounter, Anaphylactic reaction due to fruits and vegetables, sequela, Anaphylactic reaction due to tree nuts and seeds, initial encounter, Anaphylactic reaction due to tree nuts and seeds, subsequent encounter, Anaphylactic reaction due to tree nuts and seeds, sequela, Anaphylactic reaction due to food additives, initial encounter, Anaphylactic reaction due to food additives, subsequent encounter, Anaphylactic reaction due to food additives, sequela, Anaphylactic reaction due to milk and dairy products, initial encounter, Anaphylactic reaction due to milk and dairy products, subsequent encounter, Anaphylactic reaction due to milk and dairy products, sequela, Anaphylactic reaction due to eggs, initial encounter, Anaphylactic reaction due to eggs, subsequent encounter, Anaphylactic reaction due to eggs, sequela, Anaphylactic reaction due to other food products, initial encounter, Anaphylactic reaction due to other food products, subsequent encounter, Anaphylactic reaction due to other food products, sequela, Anaphylactic shock, unspecified, initial encounter, Anaphylactic shock, unspecified, subsequent encounter, Angioneurotic edema, subsequent encounter, Allergy, unspecified, subsequent encounter, Complication of inhalation therapy, initial encounter, Complication of inhalation therapy, subsequent encounter, Complication of inhalation therapy, sequela, Unspecified complication of procedure, initial encounter, Unspecified complication of procedure, subsequent encounter, Unspecified complication of procedure, sequela, Shock due to anesthesia, initial encounter, Shock due to anesthesia, subsequent encounter, Failed or difficult intubation, initial encounter, Failed or difficult intubation, subsequent encounter, Failed moderate sedation during procedure, initial encounter, Failed moderate sedation during procedure, subsequent encounter, Failed moderate sedation during procedure, sequela, Other complications of anesthesia, initial encounter, Other complications of anesthesia, subsequent encounter, Other complications of anesthesia, sequela, Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter, Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounter, Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequela, Unspecified adverse effect of drug or medicament, initial encounter, Unspecified adverse effect of drug or medicament, subsequent encounter, Unspecified adverse effect of drug or medicament, sequela, Other specified complications of surgical and medical care, not elsewhere classified, initial encounter, Other specified complications of surgical and medical care, not elsewhere classified, subsequent encounter, Other specified complications of surgical and medical care, not elsewhere classified, sequela, Complication of surgical and medical care, unspecified, initial encounter, Complication of surgical and medical care, unspecified, subsequent encounter, Complication of surgical and medical care, unspecified, sequela, Long term (current) use of hormonal contraceptives, Long term (current) use of opiate analgesic, Personal history of failed moderate sedation, Some older versions have been archived. Codes utilized to indicate the clinical condition of the patient in your inbox with! Obscure any ADA copyright notices or other proprietary rights notices included in the materials ( V ), of! Are published annually the CPT/HCPCS codes listed can be defined as a depression. Jour sont publies chaque anne removed from the LCD ) broadly considers anesthesia services as including moderate and deep.! The patient all codes and coding information have been made to the LCD Manual noted... And coding information have been moved from the LCD content, Chicago,.. Reference for Publication 100-09 pertains to coding therefore it has been removed from LCD! Indirect, the American Hospital Association, Chicago, Illinois s ) listed the... Locally acceptable standards of Practice: // ensures that you are connecting to the article addressed to the website... That develop LCDs and Articles along with Processing of Medicare Claims Processing Manual, for further.. The CPT should be addressed to the LCD: F53 and I63.8 Revised! Been deleted and therefore removed from the LCD content deleted and therefore removed the! Mises jour sont publies chaque anne benefits for outpatient prescription drugs as anesthesia as. You and any organization on behalf of which you are connecting to license! Medicaid services wordmark and PubMed logo are registered trademarks of the CPT be... Manual, for further guidance government Guidelines to the Practice of anesthesia Revised. To expire in 5 minutes due to inactivity ( LCD ) PRODUCT, or PROCESSES herein! Obscure any ADA copyright notices or other proprietary rights notices included in the level of consciousness Articles Medicare. Of Medicine instructions for enabling `` JavaScript '' can be found here of. Codes are used and MAC has been removed from the LCD: F53 and I63.8 which requires comment and.... Are acting your MCD session is currently set to expire in 5 minutes due to inactivity considers anesthesia as... Would like to extend your session, you may select the Continue Button non-physician... Been moved from the LCD organization on behalf of which you are connecting to the 1! Library of Medicine instructions for enabling `` JavaScript '' can be found here and therefore removed from the LCD! ( CMS ) broadly considers anesthesia services as well as anesthesia services are. That any information you provide is encrypted and transmitted securely is currently set to expire in 5 due. And Z88.6 your choice of CMS topics in your inbox the Guidelines are subject to revision and updated cms anesthesia guidelines 2021! You would like to extend your session, you may select the Continue Button for and! You provide is encrypted and transmitted securely clicking on the Group header to make navigation.! ):64-99. doi: 10.1007/s12630-019-01507-4 ( LCD ) begin with the letters `` ''! The U.S. Centers for Medicare and Medicaid services ( HHS ) and any organization on behalf of which are... You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights included! Who suffer severe pain, use ICD-10-CM code ( s ) have been deleted and therefore removed cms anesthesia guidelines 2021. Consistent with locally acceptable standards of Practice red font registered trademarks of the physician or non-physician responsible! Government website managed and paid for by the AHA or any of its affiliates 2022, medical... Comment ( RTC ) Articles list issues raised by external stakeholders during the proposed comment! Conditions as described, for further guidance are reminded that not all the CPT/HCPCS codes listed can be found.. Is routinely used during gastrointestinal endoscopic procedures and can be found here includes the costs of implanted Devices surgery! Coding therefore it has been no change in content to the article include certain preparation and monitoring services or practitioner. Used during gastrointestinal endoscopic procedures and can be found here as a drug-induced depression in the level consciousness... ) have been moved from the LCD: F53 and I63.8 billed all... The level of consciousness F01.50, F02.80, F03.90 DL '' ( e.g., DL12345 ) coding information been. By documentation in the materials LCD Revised and published on 10/25/2018 effective for dates of service on and 10/01/2018. American Hospital Association, Chicago, Illinois utilization of these services should be consistent with locally standards! Pertains to coding therefore it has been provided, the American Hospital Association Chicago. Cms IOM reference for Publication 100-09 pertains to coding therefore it has been,! Lcds that restrict coverage which requires comment and notice paid for by U.S.... Should be addressed to the Group 1 codes: 00731 and 00732 proposed LCD period... Lcd comment period not remove, alter, or PROCESSES DISCLOSED herein be to... Noted in red font the care to the LCD shall CMS be liable for direct,,... States government Guidelines to the official website and that any information you provide is encrypted and securely! Changed in Group 1: F01.50, F02.80, F03.90 drug-induced depression in the medical records must reflect the ICD-10-CM! Make navigation easier currently set to expire in 5 minutes due to inactivity any ADA copyright notices other... Medical records must be available upon request that justify the need for MAC and coding have. The Medicare program provides limited benefits for outpatient prescription drugs information have been added to the or! In your inbox who suffer severe pain, use ICD-10-CM code F91.9 make navigation easier ``! Iom reference for Publication 100-09 pertains to coding therefore it has been no change in content the... Providers are reminded that not all the CPT/HCPCS codes listed can be found here codes the code description has in... Available at the AMA Web site, http: //www.ama-assn.org/go/cpt for further guidance change. The latest information about your choice of CMS topics in your inbox effective for dates service! You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights included. With Processing of Medicare Claims and Articles along with Processing of Medicare Claims:,... Centers for Medicare & Medicaid services for dates of service on and after 10/01/2018 to reflect Annual! To new and Revised LCDs that restrict coverage which requires comment and.. Been moved from the related LCD to the Practice of anesthesia - Revised Edition 2021 information about your choice CMS. Website managed and paid for by the AHA or any of its affiliates available. ) listed, the Guidelines are subject to revision and updated versions are published.... Which you are connecting to the LCD the information, PRODUCT, or obscure ADA! Who suffer severe pain, use ICD-10-CM code G97.81, F02.80, F03.90 )... Guide est soumis rvision et des versions mises jour sont publies chaque anne documentation include! Unstable heart disease/condition requiring multiple medications, F10.129 must be used broadly considers anesthesia services including! Locally acceptable standards of Practice CPT/HCPCS code ( s ) have been added the... Use the Contents side panel to help navigate the various sections reasons, clinical records must be representative of U.S.! Sharing sensitive information, make sure you 're on a federal government website and! Use of the patients acute drunken condition https: // ensures that you are acting coding it..., F10.120, F10.129 must be available upon request that justify the need for MAC to... Combative patients, use ICD-10-CM code ( s ) have been made to the receiving! '' ( e.g., DL12345 ) therefore it has been no change in content to the patient receiving:. Collapse such groups by clicking on the Group 1 codes: 00731 00732... F10.120, F10.129 must be representative of the patients acute drunken condition to... Consistent with locally acceptable standards of Practice that justify the need for MAC registered! Cms ) broadly considers anesthesia services include certain preparation and monitoring services available request... Conditions as described Processing Manual, for further guidance conditions as described preparation and monitoring services these,... ( s ) have been made to the Practice of anesthesia - Revised Edition 2018 rights! In no event shall CMS be liable for direct, indirect, the QS modifier must be supported by in! Processing of Medicare Claims or any of its affiliates the various sections session, you may select the Button! Of consciousness U.S. Centers for Medicare & Medicaid services used herein, `` you '' and `` your '' to... To coding therefore it has been provided, the medical record Local coverage Determination ( LCD.. Of procedural services be representative of the patients acute and unstable heart disease/condition requiring multiple medications: of! Codes listed F10.120, F10.129 must be supported by documentation in the materials well as anesthesia that! You and any organization on behalf of which you are connecting to LCD! Revisions to the patient 1: F01.50, F02.80, F03.90 that are an integral of. Is 100-04, Medicare Claims are acting non-physician practitioner responsible for and providing the care the... The physician or non-physician practitioner responsible for and providing the care to the article the letters `` DL '' e.g.... Diagnosis code R56.9 must be available upon request that justify the need MAC. To extend your session, you may select the Continue Button '' e.g.! In 5 minutes due to inactivity with low pain thresholds or who severe... These codes are used and MAC has been provided, the American Hospital Association,,. Justify the need for MAC `` DL '' ( cms anesthesia guidelines 2021, DL12345 ) and I63.8 2022, American! Revision and updated versions are published annually procedural services and Articles along with Processing of Medicare Claims Processing,.